A new scoring system for predicting survival in patients with non-small cell lung cancer

A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

(2015) Rogerio Lilenbaum et al.   Journal of Thoracic Oncology

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Relationship Between Deficits in Overall Quality of Life and Non–Small-Cell Lung Cancer Survival

(2012) Jeff A. Sloan et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy

(2011) Branislav Jeremić et al.   CANCER

The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer

(2011) Dirk Rades et al.   CANCER

High-Dose Conformal Radiotherapy for Patients With Stage III Non–Small-Cell Lung Carcinoma

(2010) Hidetsugu Nakayama et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prognostic Impact of Erythropoietin Expression and Erythropoietin Receptor Expression on Locoregional Control and Survival of Patients Irradiated for Stage II/III Non-Small-Cell Lung Cancer

(2010) Dirk Rades et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801

(2009) Benjamin Movsas et al.   JOURNAL OF CLINICAL ONCOLOGY